Jennifer Creel
Keine laufenden Positionen mehr
Karriereverlauf von Jennifer Creel
Ehemalige bekannte Positionen von Jennifer Creel
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADC THERAPEUTICS SA | Director of Finance/CFO | 20.05.2020 | 19.12.2022 |
| CELGENE | Corporate Officer/Principal | 01.01.2008 | 01.01.2020 |
Ausbildung von Jennifer Creel
| The College of William & Mary | Undergraduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Schweiz | 2 |
Operativ
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADC THERAPEUTICS SA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Jennifer Creel
- Erfahrung
